{ "ok": true, "cik": "1106644", "ticker": "CPHI", "name": "CHINA PHARMA HOLDINGS, INC.", "filings": [ { "form": "10-Q", "filed": "2026-08-14", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1106644/000121390026090173/0001213900-26-090173-index.htm" }, { "form": "8-K", "filed": "2026-07-22", "items": [ "1.01 Entry into a Material Definitive Agreement", "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1106644/000121390026080475/0001213900-26-080475-index.htm" }, { "form": "10-Q", "filed": "2026-05-15", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1106644/000121390026057705/0001213900-26-057705-index.htm" }, { "form": "10-K", "filed": "2026-04-01", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1106644/000121390026038521/0001213900-26-038521-index.htm" }, { "form": "8-K", "filed": "2026-03-03", "items": [ "1.01 Entry into a Material Definitive Agreement", "3.02 Unregistered Sales of Equity Securities", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1106644/000121390026023022/0001213900-26-023022-index.htm" }, { "form": "8-K", "filed": "2026-02-10", "items": [ "1.01 Entry into a Material Definitive Agreement", "3.02 Unregistered Sales of Equity Securities", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1106644/000121390026014338/0001213900-26-014338-index.htm" } ], "events12m": 6, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2026-04-01", "url": "https://www.sec.gov/Archives/edgar/data/1106644/000121390026038495/0001213900-26-038495-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001106644.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1106644" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up CHINA PHARMA HOLDINGS, INC. ($CPHI). Last filing: 10-Q, 2026-08-14. 6 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 4144268, "revenueGrowth1y": -0.08493420850713274, "revenueGrowthPerYear": -0.19030581395770796, "yearsOfData": 5, "operatingMargin": -0.7815802452930167, "operatingMarginPrior": -1.0132342547211493, "netMargin": -0.7691481342422836, "operatingCashFlow": 148261, "capitalSpending": 59324, "freeCashFlow": 88937, "researchAndDevelopment": 280901, "researchShareOfRevenue": 0.06778060685264563, "cash": 345112, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 9641925 }, { "fiscalYearEnd": "2022-12-31", "revenue": 8104092 }, { "fiscalYearEnd": "2023-12-31", "revenue": 7011299 }, { "fiscalYearEnd": "2024-12-31", "revenue": 4528929 }, { "fiscalYearEnd": "2025-12-31", "revenue": 4144268 } ], "totalEquity": 22739752, "totalAssets": 30999464, "equityRatio": 0.7335530704659926, "returnOnEquity": -0.14017549531762705, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": -0.74, "sharesOutstanding": 4291427, "bookValuePerShare": 5.298878904383088, "revenuePerShare": 0.9657086092807824, "range80": { "low": 2275112.510653279, "high": 5316597.460073459, "baseline": 3553176.3997901166, "n": 2483, "band": "b000", "bandLabel": "under $50M", "method": "v4.1", "credibility": 0.625, "growthYears": 6, "ownVolatility": 0.14683624951468618, "classVolatility": 0.3000583276631395, "volatility": 0.21734460565473437 }, "ifPaceHeld": { "low": 2275112.510653279, "high": 5316597.460073459 } }, "edgarette": "🔖 Exposure: revenue $4.1M (FY2025). Experience: revenue down 8.5% on the year, down 19.0% a year over 4 years; operating margin -78.2%, up from -101.3%. Soundness: equity 73.4% of assets, return on equity -14.0%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $2.3M and $5.3M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; on a year the method never saw, 83.4% landed inside). In a shock year the stress range is $2.1M to $5.6M. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -78.2% against a -3.8% median; growth -8.5% against 13.7%.", "peers": { "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2834", "growth": [ 0.1365, 111 ], "opMargin": [ -0.038, 114 ], "equityRatio": [ 0.4028, 118 ], "returnOnEquity": [ -0.0112, 100 ], "payoutRatio": [ 0.403, 13 ] }, "summary": "China Pharma Holdings (CPHI) saw revenue fall 8.5% in FY2025 to $4 million, operating margin -78.2% against a -3.8% median for pharmaceutical preparations, equity 73.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
CHINA PHARMA HOLDINGS, INC. against its own record and its peers
Operating marginPeer median -3.8%-78.2%Revenue, on the yearPeer median 13.7%-8.5%Equity of assetsPeer median 40.3%73.4%Return on equityPeer median -1.1%-14.0%Gold tick: the median of 100–118 peers with $50M+ revenue in pharmaceutical preparations
", "chartHorizon": null, "backtest": { "tests": 12, "hits": 12, "rate": 1, "method": "v4", "byYear": { "2014": [ 1, 1 ], "2015": [ 1, 1 ], "2016": [ 1, 1 ], "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 1, 1 ], "2020": [ 1, 1 ], "2021": [ 1, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-27T22:42:58.182Z", "hash": "b898e8902add57fb", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "China Pharma Holdings (CPHI) saw revenue fall 8.5% in FY2025 to $4 million, operating margin -78.2% against a -3.8% median for pharmaceutical preparations, equity 73.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 4144268, "totalDebt": null, "cash": 345112 }, "experience": { "revenueGrowth1y": -0.08493420850713274, "revenueGrowthPerYear": -0.19030581395770796, "operatingMargin": -0.7815802452930167, "operatingMarginPrior": -1.0132342547211493, "netMargin": -0.7691481342422836, "freeCashFlow": 88937 }, "soundness": { "equityRatio": 0.7335530704659926, "returnOnEquity": -0.14017549531762705, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2834", "growth": [ 0.1365, 111 ], "opMargin": [ -0.038, 114 ], "equityRatio": [ 0.4028, 118 ], "returnOnEquity": [ -0.0112, 100 ], "payoutRatio": [ 0.403, 13 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2026-04-01", "url": "https://www.sec.gov/Archives/edgar/data/1106644/000121390026038495/0001213900-26-038495-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 2275112.510653279, "high": 5316597.460073459, "baseline": 3553176.3997901166, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 2483, "sizeBand": "under $50M", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341 }, "credibility": { "weightOnOwnRecord": 0.625, "growthYears": 6, "ownVolatility": 0.14683624951468618, "classVolatility": 0.3000583276631395, "pricedVolatility": 0.21734460565473437, "k": 3 }, "stress": { "low": 2146464.750629255, "high": 5646658.609948217, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 12, "hits": 12, "rate": 1, "method": "v4", "byYear": { "2014": [ 1, 1 ], "2015": [ 1, 1 ], "2016": [ 1, 1 ], "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 1, 1 ], "2020": [ 1, 1 ], "2021": [ 1, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-27T22:42:58.182Z", "hash": "b898e8902add57fb", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001106644.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1106644" }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.0358, "growth3y": -0.2003, "volatility": 0.1468, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.7336, "quadrant": { "code": "ss", "label": "Slow and steady", "plain": "growing slower than its size class, with steadier revenue" }, "compass": { "code": "between", "inside": "Turns 3.6% of revenue into operating cash; revenue shrinking 20.0% a year over three years; no common dividend.", "outside": "Among under $50M companies: 76th percentile for cash, 20th for growth.", "emoji": "🌊", "label": "In between", "plain": "no clear cash pattern yet" }, "band": "under $50M", "cashPctInClass": 76, "growthPctInClass": 20, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice in the last 12 months" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±40%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 2, "name": "Weathered boat", "plain": "two warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": 148261, "investing": -137251, "financing": -294027, "capitalSpending": 59324, "free": 88937, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": -249838, "free": -687893 }, { "fiscalYearEnd": "2022-12-31", "operating": -409545, "free": -811509 }, { "fiscalYearEnd": "2023-12-31", "operating": -699686, "free": -711203 }, { "fiscalYearEnd": "2024-12-31", "operating": -406063, "free": -444474 }, { "fiscalYearEnd": "2025-12-31", "operating": 148261, "free": 88937 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 345112, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 30999464, "ladder": null, "currentRatio": 0.32, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.0358, "growth3y": -0.2003, "volatility": 0.1468, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.7336, "quadrant": { "code": "ss", "label": "Slow and steady", "plain": "growing slower than its size class, with steadier revenue" }, "compass": { "code": "between", "inside": "Turns 3.6% of revenue into operating cash; revenue shrinking 20.0% a year over three years; no common dividend.", "outside": "Among under $50M companies: 76th percentile for cash, 20th for growth.", "emoji": "🌊", "label": "In between", "plain": "no clear cash pattern yet" }, "band": "under $50M", "cashPctInClass": 76, "growthPctInClass": 20, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice in the last 12 months" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±40%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 2, "name": "Weathered boat", "plain": "two warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": 148261, "investing": -137251, "financing": -294027, "capitalSpending": 59324, "free": 88937, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": -249838, "free": -687893 }, { "fiscalYearEnd": "2022-12-31", "operating": -409545, "free": -811509 }, { "fiscalYearEnd": "2023-12-31", "operating": -699686, "free": -711203 }, { "fiscalYearEnd": "2024-12-31", "operating": -406063, "free": -444474 }, { "fiscalYearEnd": "2025-12-31", "operating": 148261, "free": 88937 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 345112, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 30999464, "ladder": null, "currentRatio": 0.32, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }